IRCT20210917052506N1
Recruiting
Phase 2
Evaluation of the therapeutic efficacy and safety of dalfampridine on patients with Devic syndrome: A triple-blind randomized clinical trial study
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Devic.
- Sponsor
- Esfahan University of Medical Sciences
- Enrollment
- 70
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age between 16 to 65 years
- •T25FW\-based gait disorder: Test between 5 and 60 seconds
- •Definitive diagnosis of Devic disease based on wingerchuc criteria
- •No other neurological or psychological disease
- •No relapse during the three months prior to enrollment
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Evaluation of the therapeutic efficacy and safety of pyronaridine-artesunate for the treatment of uncomplicated falciparum malaria in areas of artemisinin-resistant falciparum malaria in Viet NamACTRN12618001274268Ministry of Health, Viet Nam153
Not Yet Recruiting
Phase 4
a clinical trial to compare efficacy of the analgesic activity of inj. Bupivacaine vs inj. Ropivacaine given at transverse abdominis block and also compare the safety parameters also.CTRI/2017/08/009249Department of Anaesthesiology
Active, Not Recruiting
Phase 1
Evaluation the safety and efficacy of the treatment of scars and cutis laxa syndrome with the use of autologous (fresh and stored) stem cells isolated from adipose tissue within the project: 'The therapeutic potential of mesenchymal stem cells tested in clinical trials and in vitro - a justification for characterized cells storage'.EUCTR2016-004110-10-PLMedical University of Warsaw100
Active, Not Recruiting
Phase 1
Evaluation of treatment effectiveness and safety of somatic cell based therapy for urinary incontinence in patients after radical prostatectomy.urinary incontinenceMedDRA version: 20.0Level: LLTClassification code: 10021643Term: Incontinence urinary Class: 10038359Therapeutic area: Diseases [C] - Male Urogenital Diseases [C12]CTIS2023-509812-27-00icolaus Copernicus University45
Recruiting
N/A
Safety evaluation and therapeutic effect analysis of knee hyperthermia with resonant cavity applicatorJPRN-UMIN000033721nternational University of Health and Welfare20